Quantcast
Skin Cancer Risks Higher For Soldiers Serving Abroad

Skin Cancer Risks Higher For Soldiers Serving Abroad

Wayne Wood, Vanderbilt University Medical Center Soldiers deployed to tropical and sunny climates are coming home with increased risk factors for a threat far from the battlefield: skin cancer. In a retrospective study of about 200 veterans...

Latest Melanoma Stories

2014-09-18 12:29:43

The Highest Percentage of Non-Prescribers Anticipate Prescribing Tafinlar and Mekinist Within the Next One to Three Months, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 18, 2014 /PRNewswire/ -- Decision Resources Group finds that at one year post-launch in the United States, 54 percent of surveyed U.S. medical oncologists have prescribed GlaxoSmithKline's BRAF inhibitor Tafinlar for BRAF-mutation-positive unresectable or metastatic melanoma, compared with 49...

2014-09-18 12:27:56

LONDON, Sept. 18, 2014 /PRNewswire/ -- This report gives you a new and unique way of stratifying and analyzing the global melanoma pipeline and presents actionable analysis which allows you to discover:* Where the competition is; Which targets and companies are setting the path?* What is first-in-class in the melanoma pipeline?* Is First-in-Class the Best-in-Class?* Indication expansion opportunities* Drug repositioning opportunities* Which pathways are targeted, by what and how?*...

2014-09-17 08:28:52

Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J., Sept. 17, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that agreement has been reached with the US Food and Drug Administration (FDA) on the design of a pivotal, Phase 3 clinical trial evaluating its...

2014-09-15 23:01:41

The study revealed that Sildenafil (Viagra) is associated with an 84 percent increased risk of the most deadly form of skin cancer. Port Washington, New York (PRWEB) September 15, 2014 Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured by medications reports that a recent study found that use of Viagra (sildenafil citrate), which is also sold under the brand Revatio, is tied to increased risks for melanoma. The...

2014-09-11 23:04:00

A Recently Published Study Found That Men Who Take Sildenafil (Viagra) Have An 84 Percent Risk of Developing Invasive Melanoma. New York NY (PRWEB) September 11, 2014 The Oliver Law Group P.C. reports that a recently published study has found that the use of Sildenafil citrate, sold as Viagra and Revatio increases the risk for developing melanoma skin cancer. Research published in the June 2014 issue of JAMA Internal Medicine showed men who said they used sildenafil, the generic name for...

2014-09-10 12:28:10

The Emergence of Keytruda--the First PD-1 Inhibitor Approved in the U.S.--is a Significant Milestone in Oncology, According to Decision Resources Group BURLINGTON, Mass., Sept. 10, 2014 /PRNewswire/ -- The recent approval of Merck & Co.'s Keytruda by the U.S. Food and Drug Administration for the treatment of malignant melanoma is a significant milestone for Merck & Co. and for the oncology immunotherapy drug market. Decision Resources Group anticipates the launch of Keytruda as the...

2014-09-05 20:21:03

Horses with melanoma are the subject of this major clinical study TAMPA, Fla., Sept. 5, 2014 /PRNewswire/ -- Morphogenesis Inc., the biotechnology firm developing ImmuneFx(TM), a cancer vaccine that has improved the longevity and quality of life for dogs, cats and horses, announces that a formal equine clinical trial for the direct injection form of the vaccine will begin later this month at a large equine facility in Missouri. Pat Lawman, PhD., co-founder and CEO of Morphogenesis...

2014-09-05 12:22:46

SPOT me(TM) campaign to provide community with free skin cancer screenings at the Dallas Cowboys season opener and Rally Day IRVING, Texas, Sept. 5, 2014 /PRNewswire/ -- The American Academy of Dermatology (Academy) is excited to announce their partnership with the Dallas Cowboys in an effort to raise awareness of skin cancer. Through this partnership, the American Academy of Dermatology will host free SPOT me(TM) skin cancer screenings at the Dallas Cowboys home opener on Sunday,...

2014-09-05 08:23:11

Newly Acquired SGX301 Orphan Drug Candidate Being Evaluated for Treatment of Cutaneous T-Cell Lymphoma PRINCETON, N.J., Sept. 5, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin). SGX301 is poised to enter...

2014-09-04 16:28:00

Statement from Tim Turnham, Executive Director, Melanoma Research Foundation WASHINGTON, Sept. 4, 2014 /PRNewswire-USNewswire/ -- Today the FDA approved Keytruda (pembrolizumab), a new treatment for advanced melanoma, the deadliest form of skin cancer. Melanoma patients have been waiting anxiously for this day, given the promising data that early studies have shown. In clinical trials, 24 percent of patients taking pembrolizumab had their tumors shrink. Most of these patients...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.